Chemomab Therapeutics Announces Collaboration with Leeds University to Further Elucidate the Role of CCL24 in Vascular Damage Associated with Systemic SclerosisPRNewsWire • 09/27/21
Chemomab Therapeutics Announces Appointment of Dale Pfost as Chief Executive OfficerPRNewsWire • 09/02/21
Chemomab Therapeutics Announces Second Quarter 2021 Financial Results and Provides a Business UpdatePRNewsWire • 08/13/21
Chemomab Therapeutics and AGC Biologics Expand Partnership to Manufacture CM-101 for Phase II/IIIPRNewsWire • 06/23/21
Chemomab Announces Poster Presentation at the International Liver Congress 2021 (EASL)PRNewsWire • 06/10/21
Chemomab Therapeutics Announces First Quarter 2021 Financial Results and Provides a Business UpdatePRNewsWire • 05/13/21
Chemomab Announces Enrollment of First Patient in Phase 2a Study of CM-101 in Non-Alcoholic Steatohepatitis (NASH)PRNewsWire • 04/26/21
Chemomab Announces Four New Appointments to the Board of Directors and Completion of PIPE FinancingPRNewsWire • 03/29/21